Revenue ($USD) : $8,197,000,000
R&D spend : $758,000,000
Employees : 22,000
Fiscal year end : 12/31/2023
CEO : Bryan Hanson

www.solventum.com

Solventum — formerly 3M Health Care — completed its spinoff from 3M in April, with its shares trading on the New York Stock Exchange under the symbol SOLV. The company operates in 38 countries, with more than 300 offices and facilities. Its business segments include medical surgical, dental, health information systems, and purification and filtration. In its first quarterly report as an independent company, Solventum’s second-quarter results beat the expectations of Wall Street analysts; the company upped its full-year revenue guidance to 0–1% growth. “As we continue to execute a complex transformation, we’re encouraged by our first financial results as an independent company and early ability to maintain business continuity,” said Solventum CEO Bryan Hanson, who left the corner office at Zimmer Biomet a year ago to lead the spinoff. “We are starting from a solid foundation and remain focused on addressing historical underperformance and spin-related topics to unlock significant value creation over time.” –CN